These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 35779378)

  • 21. Comparative effectiveness of direct oral anticoagulants and warfarin in patients with cancer and atrial fibrillation.
    Shah S; Norby FL; Datta YH; Lutsey PL; MacLehose RF; Chen LY; Alonso A
    Blood Adv; 2018 Feb; 2(3):200-209. PubMed ID: 29378726
    [TBL] [Abstract][Full Text] [Related]  

  • 22. All-Cause Mortality Risk with Direct Oral Anticoagulants and Warfarin in the Primary Treatment of Venous Thromboembolism.
    Roetker NS; Lutsey PL; Zakai NA; Alonso A; Adam TJ; MacLehose RF
    Thromb Haemost; 2018 Sep; 118(9):1637-1645. PubMed ID: 30103250
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Initiation of direct oral anticoagulants versus warfarin for venous thromboembolism: impact on time to hospital discharge.
    Basto AN; Fewel NP; Vo K; Stock EM; Ta M
    J Thromb Thrombolysis; 2018 Jan; 45(1):51-55. PubMed ID: 29086244
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Low persistence to rivaroxaban or warfarin among patients with new venous thromboembolism at a safety net academic medical center.
    Patel SM; Wang T; Outler DL; Elliott J; Knauss M; Peasah SK; Akbashev M
    J Thromb Thrombolysis; 2020 Feb; 49(2):287-293. PubMed ID: 31598931
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Safety ad efficacy of direct oral anticoagulants for extended treatment of venous thromboembolism.
    Imberti D; Pomero F; Benedetti R; Fenoglio L
    Intern Emerg Med; 2016 Oct; 11(7):895-900. PubMed ID: 27550399
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Trajectories of Oral Anticoagulation Adherence and Associated Clinical Outcomes During Long-Term Anticoagulation Among Medicare Beneficiaries With Venous Thromboembolism.
    Park H; Jones BL; Huang PL; Kang HR; Dietrich EA; DeRemer CE; Lo-Ciganic WH
    Ann Pharmacother; 2023 Dec; 57(12):1349-1360. PubMed ID: 36999519
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effectiveness and safety of rivaroxaban and warfarin in patients with unprovoked venous thromboembolism: a propensity-matched nationwide cohort study.
    Larsen TB; Skjøth F; Kjældgaard JN; Lip GYH; Nielsen PB; Søgaard M
    Lancet Haematol; 2017 May; 4(5):e237-e244. PubMed ID: 28411120
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of safety and efficacy outcomes of direct oral anticoagulants versus warfarin in normal and extreme body weights for the treatment of atrial fibrillation or venous thromboembolism.
    Novak AR; Shakowski C; Trujillo TC; Wright GC; Mueller SW; Kiser TH
    J Thromb Thrombolysis; 2022 Aug; 54(2):276-286. PubMed ID: 35689140
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Safety of direct oral anticoagulants versus traditional anticoagulants in venous thromboembolism.
    Giustozzi M; Franco L; Vedovati MC; Becattini C; Agnelli G
    J Thromb Thrombolysis; 2019 Oct; 48(3):439-453. PubMed ID: 31104194
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bleeding and thrombotic complications during treatment with direct oral anticoagulants or vitamin K antagonists in venous thromboembolic patients included in the prospective, observational START2-register.
    Palareti G; Antonucci E; Legnani C; Mastroiacovo D; Poli D; Prandoni P; Tosetto A; Pengo V; Testa S; Ageno W;
    BMJ Open; 2020 Nov; 10(11):e040449. PubMed ID: 33247017
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Safety and efficacy of oral anticoagulants in extreme weights.
    Chin-Hon J; Davenport L; Huang J; Akerman M; Hindenburg A
    Thromb Res; 2023 Nov; 231():1-6. PubMed ID: 37738772
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Direct Oral Anticoagulants Versus Warfarin for Venous Thromboembolism Prophylaxis in Patients With Nephrotic Syndrome: A Retrospective Cohort Study.
    Tijani A; Coons EM; Mizuki B; Dermady M; Stanilova K; Casey AL; Alqudsi M; Gastanaduy M; Elmayan A; Bamnolker A; Velez JCQ
    Ann Pharmacother; 2023 Jul; 57(7):787-794. PubMed ID: 36214262
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparative Clinical and Economic Outcomes Associated with Warfarin Versus Apixaban in the Treatment of Patients with Venous Thromboembolism in a Large U.S. Commercial Claims Database.
    Guo JD; Rajpura J; Hlavacek P; Keshishian A; Sah J; Delinger R; Mu Q; Mardekian J; Russ C; Okano GJ; Rosenblatt L
    J Manag Care Spec Pharm; 2020 Aug; 26(8):1017-1026. PubMed ID: 32452277
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Direct Oral Anticoagulant Therapy for Cancer-Associated Venous Thromboembolism in Routine Clinical Practice.
    Ogino Y; Ishigami T; Minamimoto Y; Kimura Y; Akiyama E; Okada K; Matsuzawa Y; Maejima N; Iwahashi N; Hibi K; Kosuge M; Ebina T; Ishikawa T; Tamura K; Kimura K
    Circ J; 2020 Jul; 84(8):1330-1338. PubMed ID: 32624519
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Management of acute venous thromboembolism among a cohort of patients discharged directly from the emergency department.
    Bungard TJ; Ritchie B; Bolt J; Semchuk WM
    BMJ Open; 2018 Oct; 8(10):e022064. PubMed ID: 30385439
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparative effectiveness and safety of direct oral anticoagulants compared to warfarin in morbidly obese patients with acute venous thromboembolism: systematic review and a meta-analysis.
    Elshafei MN; Mohamed MFH; El-Bardissy A; Ahmed MB; Abdallah I; Elewa H; Danjuma M
    J Thromb Thrombolysis; 2021 Feb; 51(2):388-396. PubMed ID: 32556939
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anticoagulant therapies for acute venous thromboembolism among a cohort of patients discharged from Canadian urban and rural hospitals.
    Bungard TJ; Ritchie B; Bolt J; Semchuk WM
    BMJ Open; 2018 Oct; 8(10):e022065. PubMed ID: 30385440
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intracranial Hemorrhage in Deep Vein Thrombosis/Pulmonary Embolus Patients Without Atrial Fibrillation.
    Lamsam L; Sussman ES; Iyer AK; Bhambhvani HP; Han SS; Skirboll S; Ratliff JK
    Stroke; 2018 Aug; 49(8):1866-1871. PubMed ID: 29991654
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Risk of Venous Thromboembolism After Receiving Prothrombin Complex Concentrate for Warfarin-associated Intracranial Hemorrhage.
    Felton D; Foley EM; Traub SJ; Vodonos A; Ganetsky M
    J Emerg Med; 2016 Jan; 50(1):1-6. PubMed ID: 26409668
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Safety and efficacy of direct oral anticoagulants over warfarin in Japanese patients with acute venous thromboembolism: A meta-analysis.
    Senoo K; Kondo Y; Miyazawa K; Isogai T; Chun YH; Kobayashi Y
    J Cardiol; 2017 May; 69(5):763-768. PubMed ID: 27502316
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.